Green Thumb Industries (GTBIF) Operating Income Growth (1y) (2020 - 2026)
Green Thumb Industries (GTBIF) Operating Income Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.02 Bn | 32.28 Bn | 1.97 Bn | 25.63% |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | -1.30% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -319.32% |
| 5 | United Therapeutics | 23.09 Bn | 20.94 Bn | 648.10 Mn | -14.89% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.54 Bn | 1.16 Bn | 97.23% |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | 719.49% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 21.25% |
| 10 | Green Thumb Industries | 1.65 Bn | 1.30 Bn | 143.65 Mn | -4.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.11% |
| Dec 31, 2025 | -66.65% |
| Sep 30, 2025 | -13.80% |
| Jun 30, 2025 | -27.00% |
| Mar 31, 2025 | -39.89% |
| Dec 31, 2024 | 13.45% |
| Sep 30, 2024 | -13.06% |
| Jun 30, 2024 | 31.55% |
| Mar 31, 2024 | 59.88% |
| Dec 31, 2023 | 213.09% |
| Sep 30, 2023 | 0.55% |
| Jun 30, 2023 | -34.05% |
| Mar 31, 2023 | -18.97% |
| Dec 31, 2022 | -181.85% |
| Sep 30, 2022 | -16.03% |
| Jun 30, 2022 | 22.43% |
| Mar 31, 2022 | 5.86% |
| Dec 31, 2021 | 15.00% |
| Sep 30, 2021 | 56.05% |
| Jun 30, 2021 | 261.93% |